Dr. Patrick Yang is currently Principal Scientist at Relypsa, Inc. He has been working in bay area for many years in various pharmaceutical companies in the field of CMC including analytical development and quality control. Dr. Yang obtained his Ph. D. in pharmaceutical sciences from University of the Pacific, USA.
Patrick has been serving on CBA board for several terms since 2003. His roles include directors of membership, activity, and alliance. He successfully organized CBA education seminar "Dragon Parents Summit Talk", and has been working as a committee member for Ho Family Scholarship. Besides CBA board member's duty, Patrick also participated many other activities in the Bay Area. He helped organize a big literature seminar for Sichuan earthquake fundraising, led local student math team and science bowl teams, took judge and judge leader roles in Silicon Valley science fair, and served as CABS journal editor "Trends in Bio/Pharmaceutical Industry" for seven years. He is also an active writer with many readers.
Dr. Katherine Wang, Treasurer Katherine Wang got her B.S. degree in Optics from Shandong University, and Ph.D. in Physics from Syracuse University. She worked as research scientist in Neurodegenerative Diseases Center of University of Virginia. She has years of Hands-on experiences in optical engineering, DNA sequencing, protein purification, drug-protein interactions and cell culture. Professionally trained as physicist, later she discovered that her real interest is in clinical data analysis. She is currently doing statistical programming after she led clinical programming projects at Gilead Sciences for around two years. Previously she worked as certified advanced SAS programmer and data manager as well in Clinovo. Katherine’s diligent work and enthusiasm have been well recognized. She enjoys reading, writing and Scottish Country Dancing.
Vivian Fu, Ph.D, CBA Membership Dr. Fu received her Master degree in Immunology from Xi’an Jiaotong University, and Ph.D from Department of Pathology and Cell Biology at the University of South Florida. After graduation, she joined Moffitt Cancer Center as a Postdoc and worked on drug discovery and drug development. In 2013, Dr. Fu joined Bio-Rad as a Data Scientist and built Bio-Rad business intelligence platform and helped R&D, marketing, and sales teams on Business Development strategy, New Product Development, OEM decision, and marketing campaign.